As an assignment from the Swedish Environmental Protection Agency, IVL has during 2006/2007performed a "Screening Study" of pharmaceuticals. The overall objectives of the screening were todetermine the concentrations of the selected substances in a variety of media in the Swedishenvironment, to highlight important transport pathways, and to assess the possibility of currentemissions in Sweden.Pharmaceuticals are frequently spread by domestic use and the screening programme was thusfocused on sewage treatment plants and landfills. The importance of diffusive spreading of thepharmaceuticals in an urban area was further investigated in the Stockholm area where water,sediment and biota samples were collected. Environmental background levels in water andsediment were determined in samples from three background lakes where the influence fromhuman activities was considered minor. The number of samples are listed in the table below.SurfaceWater Sediment SewageWaterLeachateWater Sludge Biota TotalRegional 9 - 42 2 19 - 72National 9 9 12 3 14 9 56Total 18 9 54 5 33 9 128All pharmaceuticals included in this screening study purposely affect the human nervous system,having the ATC-main code ‘N’. In 2006 the Swedish consumption of drugs of this therapeutic usewas 825 million Defined Daily Doses corresponding to a net cost of 6 104 million SEK. Thecentral nervous system (CNS) represents the largest part of the nervous system, including the brainand the spinal cord. Together with the peripheral nervous system, it has a fundamental role in thecontrol of behaviour. The basic pattern of the CNS is highly conserved throughout the differentspecies of vertebrates and during evolution.Pharmaceuticals included in this screening study were; analgetics (fentanyl, dextropropoxyphene),anestetics (propofol), dopaminergic agonists (bromokriptine), neuroleptics (thioridazine),dibenzoxazepines (clozapine), benzodiazepines (flunitrazepam, diazepam and oxazepam), antipsychotics (risperidone), sedatives (zolpidem) and selective serotonine re-uptake inhibitors, SSRIs(sertraline, fluoxetine,citalopram and paroxetine).Oxazepam was the most frequently detected substance in water as well as the substance beingfound in the highest concentrations in sewage water samples. Furthermore, it was the onlysubstance being detected in surface water samples. This can not entirely be explained by its salesvolume (640 kg). Another factor that has to be considered is the tendency for otherbenzodiazepines to metabolise into this substance. Oxazepam has a rather low log Kow of 2.2 butwas nevertheless also detected STP sludge.Risperidone is sold in minor quantities in Sweden (8-20 kg) but is still detected in both influent andeffluent waters. However, despite having a log Kow of 3.49, risperidone was still not detected insludge. Among the three substances with the highest sales volumes, sertraline, dextropropoxypheneand citalopram, only citalopram could be detected in the sewage water samples. None of the Results from the Swedish screening 2006 IVL report B1751Subreport 4: Pharmaceuticals2substances were detected in surface water. Thus, no clear correlation between sales volumes andconcentrations in sewage water was identified in this study.Factors such as degradation and the tendency to adsorb to sludge seem to influence the fate of thesubstances but no clear correlation between lipofilicity and the tendency to end up in sewageeffluent can be drawn from these results. Factors such as the adsorption to solid matter; chelation,ionic interaction and chemisorption must also be considered to get a better understanding of thepartioning behaviour of pharmaceuticals.Considering both aqueous and solid matrices citralopram is the most frequently encounteredpharmaceutical. Sertraline was however found in the highest concentrations in sludge and also hasone of the highest log Kow (5.29) among the pharmaceuticals in this study. Citalopram, with a logKow of 3.74, was also frequently found in sludge while dextropropoxyphene, with a log Kow of4.18, was only detected once in sludge and then in a concentration close to the detection limit.Citalopram was detected in several sediment samples while sertraline was only detected in onesediment sample.Among the metabolites, zoplicone-n-oxide (metabolite of zopiclone), 7-aminoflunitrazepam(metabolite of flunitrazepam) and nordiazepam (metabolite of diazepam) were detected in watersamples. Norfentanyl (metabolite of fentanyl) was detected in sludge.Caffeine was introduced to the sampling scheme as an indicator for human influence. Caffeine wassubsequently found in all environmental water samples where pharmaceuticals were detected. In thebackground lake Lilla Öresjön, where no pharmaceutical residues were expected to be found, thesubstance flunitrazepam along with caffeine was detected indicating a release of sewage water fromhouses not affiliated to any municipal sewage treatment plant.Another marker for anthropogenic sources applicable when investigating pharmaceuticals ishydroxyl ibuprofen (metabolite of ibuprofen). Hydroxy ibuprofen was detected in all STP influentwater samples and was also frequently encountered in the effluent water samples. Both caffeineand hydroxy ibuprofen concentrations in influent water showed a slight correlation with thecorresponding citalopram- and oxazepam concentrations.